Across TCGA pan-cancer cohorts, MIR216A Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MIR216A data layer compared with 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR216A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR216A expression acts as an unfavorable survival marker.

COAD and SKCM are the cancer types where MIR216A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.111	0.871	<.001	24	view →
SKCM	OS	Median	All	0.245	0.781	.008	11	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR216A tumor-vs-normal RNA expression · all MIR216A data types